期刊
ANIMALS
卷 12, 期 16, 页码 -出版社
MDPI
DOI: 10.3390/ani12162084
关键词
sheeppox; emergency vaccination; Egypt; control; outbreak
Sheeppox is an emerging disease that has a significant impact on animal health and production worldwide. Emergency vaccination, particularly with the RM-65 vaccine, has been shown to be effective in controlling and preventing sheeppox outbreaks. Comparative field evaluation of vaccines highlights the superiority of RM-65 over the Romanian strain vaccine in protecting animals against sheeppox, emphasizing the importance of emergency vaccination in outbreak control.
Simple Summary Sheeppox is an emerging disease in different parts of the world with a huge impact on animal health and production. Emergency vaccination might be an effective strategy to overcome this disease. In this study we characterized in detail an outbreak of sheeppox in a susceptible naive sheep population in Egypt. The local and the systemic signs as well as postmortem and the histopathological findings of the disease were confirmed. We also compared the efficacies of two commercial sheeppox vaccines (Romanian strain and RM-65 vaccines). Our results confirmed the superiority of the RM-65 vaccine compared to the Romanian strain vaccine in protecting the animals. Furthermore, we highlighted the validity of emergency vaccination to control a sheeppox outbreak. This study aimed to investigate a sheeppox outbreak in a highly susceptible naive sheep population in Kharsit village, Gharbia Governorate, Egypt. Moreover, to compare commercial sheeppox vaccines, the Romanian strain and RM-65 vaccines, as emergency vaccination against sheeppox under field conditions. In December 2018, a sheeppox outbreak occurred in a flock of 65 sheep upon the purchase of an apparently healthy ewe from outside the village. This ewe showed a systemic disease with cutaneous lesions after a few days, thereafter more cases began to appear. Cutaneous lesions in other sheep in the flock in the form of macules, papules, and scabs were common in wool-less areas of the body, in addition to fever and respiratory disorders. Postmortem findings revealed the congestion of visceral organs with apparent gross pathology of the lung. Biopsies of cutaneous lesions and visceral organs were collected, and sheeppox was identified by histopathology and transmission electron microscopy, which showed the existence of sheeppox cells and intracytoplasmic brick-shape sheeppox virions. The Romanian strain and RM-65 vaccines were used for the emergency vaccination for two different groups of animals and the third group was left as a control group. Serum samples were collected before vaccination as well as 21 days post-vaccination, and serum protein fractionation analysis was performed for all groups. The outbreak ended after 2.5 months, the cumulative incidence was 66.2%, and the overall case fatality was 51.1%. There was significantly higher protection against sheeppox infection and mortalities among RM-65 vaccine immunized group compared to Romanian strain vaccine-immunized animals at p < 0.05. RM-65-vaccinated animals did not show sheeppox cases or mortalities, compared to Romanian strain-vaccinated animals, which had mild pox signs in 78% of animals and case fatality of 35.7%. The serum protein analysis also indicated the superior performance of the RM-65 vaccine; it increased the level of alpha 1-globulin and beta-globulin compared to the Romanian strain, which increased the level of beta-globulin only. The current study shows a better performance of the tested RM-65 than the Romanian strain vaccine for emergency vaccination against sheeppox under field conditions. These findings point to the validity of emergency vaccination against sheeppox and the importance of the comparative field evaluation of vaccines; however, wide-scale studies are required for further evaluation. Future investigation of whether the Romanian strain itself or vaccine-production-related issues are responsible for these findings is required.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据